Back to Search
Start Over
Elsberg syndrome following acute immunosuppressive treatment for multiple sclerosis relapse.
- Source :
-
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2022 Feb; Vol. 58, pp. 103498. Date of Electronic Publication: 2022 Jan 04. - Publication Year :
- 2022
-
Abstract
- First described more than 80 years ago, Elsberg Syndrome (ES) continues to be an under-recognized cause of cauda equina syndrome (CES). ES is an infectious disorder that presents with lower thoracic and/or lumbosacral myelitis in conjunction with CES, and most often occurs in the setting of herpes simplex virus 2 (HSV-2) reactivation (Savoldi et al., 2017; Eberhardt et al., 2004; Whalen et al., 2019). Comorbid neurologic diseases like multiple sclerosis (MS) can become a detrimental confounding factor leading to delayed diagnosis and management of ES due to pre-existing diagnostic bias. We present a case of relapsing-remitting MS (RRMS) complicated by ES, likely due to reactivation of a latent HSV infection following high immunosuppression for presumed refractory MS relapses.<br /> (Copyright © 2022 Elsevier B.V. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 2211-0356
- Volume :
- 58
- Database :
- MEDLINE
- Journal :
- Multiple sclerosis and related disorders
- Publication Type :
- Report
- Accession number :
- 35007821
- Full Text :
- https://doi.org/10.1016/j.msard.2022.103498